Skip to main content
Clinical Trials/NCT06099002
NCT06099002
Completed
Not Applicable

Balance, Walking Speed, Quadriceps Femoris Muscle Strength and Quality of Life in Falling and Non-falling Individuals With COPD

Kırıkkale University1 site in 1 country74 target enrollmentDecember 30, 2023
ConditionsCopd

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Copd
Sponsor
Kırıkkale University
Enrollment
74
Locations
1
Primary Endpoint
Fall Effectiveness Scale
Status
Completed
Last Updated
last year

Overview

Brief Summary

A descriptive study evaluating balance, gait speed, Quadriceps Femoris muscle strength and quality of life in individuals with Chronic obstructive pulmonary disease (COPD) who fell and did not fall.

Detailed Description

Falls in the elderly can have devastating consequences. The ability to maintain stability and balance is critical for functional independence, mobility, and avoidance of falls in activities of daily living. An impaired balance is associated with an increased risk of falls and causes a higher mortality rate among older adults. Balance impairment is independently associated with falls in patients with Chronic obstructive pulmonary disease. Well-known risk factors for falls in individuals with Chronic obstructive pulmonary disease include advanced age, increased comorbidities, dyspnea, physical inactivity, muscle weakness, fear and decreased balance confidence, as well as lower extremity muscle weakness. It has been reported that there are functional deficiencies, lack of performance and postural control. According to the results of a recent study, it was found that Chronic obstructive pulmonary disease is in the second place after osteoarthritis in chronic conditions where the prevalence of falls is highest. The prevalence of falls in individuals with Chronic obstructive pulmonary disease is estimated to range from 25% to 46%.

Registry
clinicaltrials.gov
Start Date
December 30, 2023
End Date
May 30, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Kırıkkale University
Responsible Party
Principal Investigator
Principal Investigator

Meral SERTEL

associate professor

Kırıkkale University

Eligibility Criteria

Inclusion Criteria

  • Being diagnosed with COPD according to criteria
  • Not having had an attack in the last 2 months
  • Volunteering to participate in the study
  • Being 65 years or older
  • Not having any mental or communication problems that prevent filling out the surveys to be used in the research.

Exclusion Criteria

  • Having unstable COPD
  • Unstable angina, previous Myocardial Infarction, uncontrolled hypertension, cancer, neurological or musculoskeletal diseases with functional limitations
  • Being currently addicted to alcohol or drugs
  • Being in the process of COPD exacerbation
  • Having severe vision and hearing problems
  • Having severe cognitive impairment
  • Having had major surgery in the last few months

Outcomes

Primary Outcomes

Fall Effectiveness Scale

Time Frame: 15.04.2023-30.09.2024

It contains 10 questions. Each question is given a score between 1-10. 1 point means very confident, 10 points means not at all confident. A patient with a score above 70 is said to have a fear of falling.

Secondary Outcomes

  • To measure balance Berg Balance Scala(15.04.2023-30.09.2024)
  • Quadriceps Femoris muscle strength falling and non-falling individuals with COPD(15.04.2023-30.09.2024)
  • Two Minute Walk Test(15.04.2023-30.09.2024)

Study Sites (1)

Loading locations...

Similar Trials